BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dou Z, Zhao D, Chen X, Xu C, Jin X, Zhang X, Wang Y, Xie X, Li Q, Di C, Zhang H. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation. J Exp Clin Cancer Res 2021;40:194. [PMID: 34118966 DOI: 10.1186/s13046-021-02001-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Rosa N, Speelman-Rooms F, Parys JB, Bultynck G. Modulation of Ca2+ signaling by antiapoptotic Bcl-2 versus Bcl-xL: From molecular mechanisms to relevance for cancer cell survival. Biochim Biophys Acta Rev Cancer 2022;:188791. [PMID: 36162541 DOI: 10.1016/j.bbcan.2022.188791] [Reference Citation Analysis]
2 Pan YJ, Liu BW, Pei DS. The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application. DNA Cell Biol 2022. [PMID: 35947859 DOI: 10.1089/dna.2022.0322] [Reference Citation Analysis]
3 Stanley RF, Abdel-wahab O. Dysregulation and therapeutic targeting of RNA splicing in cancer. Nat Cancer 2022;3:536-546. [DOI: 10.1038/s43018-022-00384-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ouyang J, Zhong Y, Zhang Y, Yang L, Wu P, Hou X, Xiong F, Li X, Zhang S, Gong Z, He Y, Tang Y, Zhang W, Xiang B, Zhou M, Ma J, Li Y, Li G, Zeng Z, Guo C, Xiong W. Long non-coding RNAs are involved in alternative splicing and promote cancer progression. Br J Cancer 2021. [PMID: 34750493 DOI: 10.1038/s41416-021-01600-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]